Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) - Global Forecast to 2021

アフェレーシスの世界市場予測(~2021年):血漿分離器、血漿成分分離器、血液灌流、消耗品

◆タイトル:Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) - Global Forecast to 2021
◆商品コード:MAM-MD-1407
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年2月20日
◆ページ数:215
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、アフェレーシスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別分析、処置別分析、用途別分析、技術別分析、アフェレーシスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global apheresis market is projected to reach USD 2.06 billion by 2021, at a CAGR of 7.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising prevalence of chronic diseases and growing number of complex surgeries. Similarly, the increasing number of organ transplant procedures also supports the growth of the market.
In this report, the market is segmented by product, procedure, technology, application, and region. Based on technology, the market is mainly segmented into centrifugation and membrane separation technologies. The centrifugation technology segment accounted for the largest share in 2015. This segment is also projected to register the highest growth during the forecast period. The large share and high growth in this market can be attributed to the advantages offered by centrifugation over membrane separation. Centrifugation is used for the apheresis of any blood component, whereas the use of membrane separation is limited to plasma collection and plasma exchange, and it cannot remove cellular elements.

Based on application, the market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, and other applications. In 2015, the plasmapheresis segment accounted for the largest share of the market. Growth in the plasmapheresis segment can be attributed to the increasing use of plasma fractionation products in the treatment of various diseases and the growing demand for plasma and its components from pharmaceutical and biopharmaceutical companies.

In 2015, North America commanded the largest share of the market, followed by Europe. The U.S. is a prime market for apheresis due to greater accessibility to advanced blood collection technologies and presence of a well-established healthcare infrastructure in the country. The Asia-Pacific market is expected to witness the highest growth in the coming years primarily due to the growing focus of manufacturers in this region.

Major players in the global apheresis market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan).

Research Coverage

• Detailed insights on all the submarkets, based on application (plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, and other applications), this can help market players to identify high growth segments in the apheresis market.

• The report also provides information on key players in this market and their growth strategies and recent developments. This can help the company to assess the competition at global and regional levels in a better manner.

• Key insights and market sizing for the different therapeutic procedures of the apheresis market, namely, therapeutic plasma exchange (TPE), therapeutic cytapheresis, photopheresis, and extracorporeal immunoadsorption (ECI).

• Country-wise market size and forecast for all the subsegments. Thus, not only the high growth product, procedure, technology, and application; the market size numbers provided in the report will also enable market players to identify key geographic markets, and thereby strategize global marketing efforts to achieve sustainable revenue growth in the coming years.

• It provides key insights on market dynamics, such as drivers, restraints, opportunities, and challenges for this market.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies to increase market shares.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by top players in the apheresis market. The report analyzes the market by product type across all regions
• Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the apheresis market
• Market Development: Comprehensive information on lucrative emerging markets, based on product, procedure, technology, application, and region
• Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the apheresis market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of leading players in the apheresis market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 20
1.5 LIMITATIONS 20
1.6 STAKEHOLDERS 21

2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
2.1.1 SECONDARY DATA 23
2.1.1.1 Key data from secondary sources 23
2.1.2 PRIMARY DATA 24
2.1.2.1 Key data from primary sources 24
2.1.2.2 Key industry insights 25
2.2 MARKET SIZE ESTIMATION 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.4 MARKET SHARE ESTIMATION 28
2.4.1 ASSUMPTIONS FOR THE STUDY 28

3 EXECUTIVE SUMMARY 29

4 PREMIUM INSIGHTS 36
4.1 APHERESIS: MARKET OVERVIEW 36
4.2 ASIA-PACIFIC: APHERESIS MARKET, BY APPLICATION 37
4.3 GEOGRAPHIC SNAPSHOT OF THE APHERESIS MARKET 38
4.4 GEOGRAPHIC MIX: APHERESIS MARKET 39
4.5 APHERESIS MARKET: DEVELOPING VS. DEVELOPED MARKETS 39

5 MARKET OVERVIEW 40
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
5.2.1 MARKET DRIVERS 42
5.2.1.1 Rising prevalence of diseases and growing number of trauma and injury cases 42
5.2.1.2 Increasing demand for source plasma from biopharmaceutical companies 44
5.2.1.3 Rising demand for blood components and growing concerns regarding blood safety 45
5.2.1.4 Increase in the number of complex surgical procedures 45
5.2.1.5 Favorable reimbursement policies for apheresis procedures 46
5.2.2 MARKET RESTRAINTS 46
5.2.2.1 Lack of awareness about apheresis procedures 47
5.2.2.2 High cost of apheresis devices and procedures 47
5.2.2.3 Scarcity of qualified donors 47
5.2.3 MARKET OPPORTUNITIES 48
5.2.3.1 Extending the reach of apheresis in the untapped pediatric segment 48
5.2.3.2 Emerging economies with increasing investments from government bodies and leading players 48
5.2.4 MARKET CHALLENGES 49
5.2.4.1 Recruitment of voluntary non-remunerated donors 49
5.2.4.2 Blood transfusion safety in developing countries 50

6 INDUSTRY INSIGHTS 51
6.1 INTRODUCTION 51
6.2 INDUSTRY TRENDS 51
6.2.1 NEW INDICATIONS FOR PLASMA PRODUCTS 51
6.2.2 GROWING NUMBER OF AGREEMENTS AND PARTNERSHIPS 51
6.3 PORTER’S FIVE FORCE ANALYSIS 53
6.3.1 THREAT OF NEW ENTRANTS 53
6.3.2 THREAT OF SUBSTITUTES 54
6.3.3 BARGAINING POWER OF SUPPLIERS 54
6.3.4 BARGAINING POWER OF BUYERS 54
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 55
6.4 VENDOR BENCHMARKING 55
6.4.1 PRODUCT PORTFOLIO ANALYSIS: APHERESIS MARKET 55
6.5 REGULATORY ANALYSIS 57
6.5.1 NORTH AMERICA 57
6.5.1.1 U.S. 57
6.5.1.2 Canada 58
6.5.2 EUROPE 58
6.5.3 ASIA-PACIFIC 59
6.5.3.1 Japan 59
6.5.3.2 China 59
6.5.3.3 India 60

7 GLOBAL APHERESIS MARKET, BY PROCEDURE 61
7.1 INTRODUCTION 62
7.2 AUTOMATED/APHERESIS BLOOD COLLECTION (DONOR APHERESIS) 63
7.3 THERAPEUTIC APHERESIS 64
7.3.1 THERAPEUTIC APHERESIS MARKET, BY DISEASE 65
7.3.1.1 Neurological Disorders 67
7.3.1.2 Blood Disorders 69
7.3.1.3 Cardiovascular Disorders 70
7.3.1.4 Renal Disorders 71
7.3.1.5 Autoimmune Disorders 72
7.3.1.6 Metabolic Disorders 73
7.3.1.7 Other Disorders 75
7.3.2 THERAPEUTIC APHERESIS MARKET, BY PROCEDURE 76
7.3.2.1 Therapeutic Plasma Exchange (TPE) 76
7.3.2.2 Therapeutic Cytapheresis 78
7.3.2.2.1 Therapeutic Erythrocytapheresis 79
7.3.2.2.2 Therapeutic Plateletphersis 80
7.3.2.2.3 Leukapheresis 81
7.3.2.3 Photopheresis 83
7.3.2.4 Extracorporeal Immunoadsorption (ECI) 84

8 GLOBAL APHERESIS MARKET, BY PRODUCT 85
8.1 INTRODUCTION 86
8.2 APHERESIS DEVICES 87
8.2.1 PLASMA SEPARATORS 90
8.2.2 PLASMA COMPONENT SEPARATORS 91
8.2.3 IMMUNOADSORPTION COLUMNS 92
8.2.4 PLASMA PERFUSION COLUMNS 93
8.2.5 HEMOPERFUSION COLUMNS 94
8.3 APHERESIS DISPOSABLES 95

9 GLOBAL APHERESIS MARKET, BY TECHNOLOGY 97
9.1 INTRODUCTION 98
9.2 CENTRIFUGATION 99
9.2.1 INTERMITTENT FLOW 101
9.2.2 CONTINUOUS FLOW 102
9.3 MEMBRANE SEPARATION 103

10 GLOBAL APHERESIS MARKET, BY APPLICATION 105
10.1 INTRODUCTION 106
10.2 PLASMAPHERESIS 107
10.3 PLATELETPHERESIS 108
10.4 ERYTHROCYTAPHERESIS 109
10.5 LEUKAPHERESIS 110
10.6 OTHER APPLICATIONS 111

11 APHERESIS MARKET, BY REGION 113
11.1 INTRODUCTION 114
11.2 NORTH AMERICA 116
11.2.1 U.S. 120
11.2.2 CANADA 122
11.3 EUROPE 124
11.3.1 GERMANY 128
11.3.2 FRANCE 130
11.3.3 U.K. 132
11.3.4 ITALY 134
11.3.5 SPAIN 136
11.3.6 REST OF EUROPE (ROE) 138
11.4 ASIA-PACIFIC (APAC) 140
11.4.1 JAPAN 144
11.4.2 CHINA 146
11.4.3 INDIA 148
11.4.4 REST OF ASIA-PACIFIC (ROAPAC) 150
11.5 LATIN AMERICA 152
11.5.1 BRAZIL 155
11.5.2 MEXICO 157
11.5.3 REST OF LATIN AMERICA (ROLA) 159
11.6 MIDDLE EAST AND AFRICA 161

12 COMPETITIVE LANDSCAPE 164
12.1 OVERVIEW 164
12.2 MARKET SHARE ANALYSIS 165
12.3 COMPETITIVE SITUATION AND TRENDS 166
12.4 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 166
12.5 MERGERS AND ACQUISITIONS 167
12.6 EXPANSIONS 168
12.7 PRODUCT LAUNCHES 168
12.8 OTHER STRATEGIES 169

13 COMPANY PROFILES 170
(Overview, Products & Services, Strategies & Insights, Developments and MnM View)*
13.1 INTRODUCTION 170
13.2 CERUS CORPORATION 171
13.3 FRESENIUS SE & CO. KGAA 175
13.4 ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF ASAHI KASEI CORPORATION) 178
13.5 HAEMONETICS CORPORATION 180
13.6 TERUMO BCT, INC. 183
13.7 HEMACARE CORPORATION 186
13.8 B. BRAUN MELSUNGEN AG 188
13.9 KANEKA CORPORATION 190
13.10 KAWASUMI LABORATORIES INC. 192
13.11 NIKKISO CO., LTD. 194
*Details on Overview, Products & Services, Strategies & Insights, Developments and MnM View might not be captured in case of unlisted companies.

14 APPENDIX 196
14.1 INSIGHTS OF INDUSTRY EXPERTS 196
14.2 DISCUSSION GUIDE 197
14.3 OTHER DEVELOPMENTS 202
14.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 206
14.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 208
14.6 AVAILABLE CUSTOMIZATIONS 210
14.7 RELATED REPORTS 211
14.8 AUTHOR DETAILS 212

LIST OF TABLES

TABLE 1 GLOBAL APHERESIS MARKET SNAPSHOT 29
TABLE 2 INCREASING DEMAND FOR SOURCE PLASMA FROM BIOPHARMACEUTICAL COMPANIES TO DRIVE MARKET GROWTH 42
TABLE 3 REQUIRED UNITS OF BLOOD AND BLOOD COMPONENTS, BY TYPE OF SURGERY 45
TABLE 4 U.S.: PAYMENT RATES FOR APHERESIS PROCEDURES FOR THE YEAR 2016 & 2017 46
TABLE 5 LACK OF AWARENESS & CHALLENGES IN DONOR RECRUITMENT TO RESTRICT MARKET GROWTH 46
TABLE 6 FREQUENCY OF BLOOD DONATIONS FROM HEALTHY DONORS 47
TABLE 7 EXTENDING THE REACH OF APHERESIS IN THE UNTAPPED PEDIATRIC SEGMENT OFFERS SIGNIFICANT GROWTH OPPORTUNITIES 48
TABLE 8 RECRUITMENT OF VOLUNTARY NON-REMUNERATED DONORS IS A MAJOR CHALLENGE IN THE MARKET 49
TABLE 9 GLOBAL APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 62
TABLE 10 GLOBAL APHERESIS MARKET SIZE FOR AUTOMATED BLOOD COLLECTION,
BY COUNTRY, 2014–2021 (USD MILLION) 64
TABLE 11 GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY COUNTRY,
2014–2021, (USD MILLION) 65
TABLE 12 GLOBAL ESTIMATED DISABILITY-ADJUSTED LIFE YEARS (DALYS), BY DISEASE, 2015-2030 (POPULATION IN 000’) 66
TABLE 13 GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY DISEASE,
2014–2021, (USD MILLION) 66
TABLE 14 NEUROLOGICAL DISORDERS: ESTIMATED DALYS BY REGION, 2015-2030 (000’) 67
TABLE 15 NEUROLOGICAL DISEASES/DISORDERS TREATED BY THERAPEUTIC APHERESIS 68
TABLE 16 GLOBAL APHERESIS MARKET SIZE FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2014–2021, (USD MILLION) 68
TABLE 17 GLOBAL APHERESIS MARKET SIZE FOR BLOOD DISORDERS, BY COUNTRY,
2014–2021, (USD MILLION) 69
TABLE 18 CARDIOVASCULAR DISORDERS: ESTIMATED DALYS, BY REGION,
2015–2030 (000’) 70
TABLE 19 GLOBAL APHERESIS MARKET SIZE FOR CARDIOVASCULAR DISORDERS,
BY COUNTRY, 2014–2021, (USD MILLION) 71
TABLE 20 GLOBAL APHERESIS MARKET SIZE FOR RENAL DISORDERS, BY COUNTRY,
2014–2021, (USD MILLION) 72
TABLE 21 GLOBAL APHERESIS MARKET SIZE FOR AUTOIMMUNE DISORDERS, BY COUNTRY, 2014–2021, (USD MILLION) 73
TABLE 22 DIGESTIVE DISORDERS: ESTIMATED DALYS BY REGION, 2015-2030 (000’) 74
TABLE 23 GLOBAL APHERESIS MARKET SIZE FOR METABOLIC DISORDERS, BY COUNTRY, 2014–2021, (USD MILLION) 74
TABLE 24 RHEUMATOID ARTHRITIS: ESTIMATED DALYS BY REGION, 2015-2030 (000’) 75
TABLE 25 GLOBAL APHERESIS MARKET SIZE, FOR OTHER DISORDERS, BY COUNTRY,
2014–2021, (USD MILLION) 75
TABLE 26 GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY PROCEDURE,
2014–2021, (USD MILLION) 76
TABLE 27 GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY,
2014–2021, (USD MILLION) 77
TABLE 28 GLOBAL THERAPEUTIC CYTAPHERESIS MARKET SIZE, BY COUNTRY,
2014–2021, (USD MILLION) 78
TABLE 29 GLOBAL THERAPEUTIC CYTAPHERESIS MARKET SIZE, BY PROCEDURE,
2014–2021, (USD MILLION) 79
TABLE 30 GLOBAL THERAPEUTIC ERYTHROCYTAPHERESIS DEVICES MARKET SIZE,
BY COUNTRY, 2014–2021, (USD MILLION) 80
TABLE 31 GLOBAL THERAPEUTIC PLATELETPHERESIS MARKET SIZE, BY COUNTRY,
2014–2021, (USD MILLION) 81
TABLE 32 LEUKEMIA: ESTIMATED DALYS BY REGION, 2015-2030 (000’) 82
TABLE 33 GLOBAL LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 82
TABLE 34 GLOBAL PHOTOPHERESIS MARKET SIZE, BY COUNTRY,
2014–2021, (USD MILLION) 83
TABLE 35 GLOBAL EXTRACORPOREAL IMMUNOADSORPTION MARKET SIZE, BY COUNTRY, 2014–2021, (USD MILLION) 84
TABLE 36 GLOBAL APHERESIS MARKET, BY PRODUCT, 2014–2021 (USD MILLION) 86
TABLE 37 APHERESIS DEVICES/SYSTEMS IN THE MARKET 87
TABLE 38 GLOBAL APHERESIS DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 89
TABLE 39 GLOBAL APHERESIS DEVICES MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 90
TABLE 40 GLOBAL PLASMA SEPARATORS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 91
TABLE 41 GLOBAL PLASMA COMPONENT SEPARATORS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 92
TABLE 42 GLOBAL IMMUNOADSORPTION COLUMNS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 93
TABLE 43 GLOBAL PLASMA PERFUSION COLUMNS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 94
TABLE 44 GLOBAL HEMOPERFUSION COLUMNS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 95
TABLE 45 GLOBAL APHERESIS DISPOSABLES MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 96
TABLE 46 GLOBAL APHERESIS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 98
TABLE 47 CENTRIFUGATION-BASED APHERESIS DEVICES 99
TABLE 48 GLOBAL CENTRIFUGATION MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 100
TABLE 49 GLOBAL CENTRIFUGATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 100
TABLE 50 GLOBAL INTERMITTENT FLOW MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 101
TABLE 51 GLOBAL CONTINUOUS FLOW MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 102
TABLE 52 SIZE OF BLOOD COMPONENTS 103
TABLE 53 MEMBRANE SEPARATION-BASED APHERESIS DEVICES 103
TABLE 54 GLOBAL MEMBRANE SEPARATION MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 104
TABLE 55 GLOBAL APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 106
TABLE 56 TOTAL SOURCE PLASMA COLLECTION IN THE U.S. & EUROPE, 2006–2015 (THOUSAND LITERS) 107
TABLE 57 GLOBAL APHERESIS MARKET SIZE FOR PLASMAPHERESIS, BY COUNTRY,
2014–2021 (USD MILLION) 108
TABLE 58 GLOBAL APHERESIS MARKET SIZE FOR PLATELETPHERESIS, BY COUNTRY,
2014–2021 (USD MILLION) 109
TABLE 59 GLOBAL APHERESIS MARKET SIZE FOR ERYTHROCYTAPHERESIS, BY COUNTRY, 2014–2021 (USD MILLION) 110
TABLE 60 GLOBAL APHERESIS MARKET SIZE FOR LEUKAPHERESIS, BY COUNTRY,
2014–2021 (USD MILLION) 111
TABLE 61 GLOBAL APHERESIS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 112
TABLE 62 GLOBAL APHERESIS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 115
TABLE 63 GLOBAL APHERESIS MARKET SIZE, BY COUNTRY/REGION,
2014–2021 (USD MILLION) 116
TABLE 64 NORTH AMERICA: TOTAL HEMOPHILIA PATIENTS, 2013 VS. 2014 VS. 2015 117
TABLE 65 NORTH AMERICA: APHERESIS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 118
TABLE 66 NORTH AMERICA: APHERESIS MARKET SIZE, BY PROCEDURE,
2014–2021 (USD MILLION) 118
TABLE 67 NORTH AMERICA: APHERESIS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 118
TABLE 68 NORTH AMERICA: APHERESIS MARKET SIZE, BY DEVICE TYPE,
2014–2021 (USD MILLION) 119
TABLE 69 NORTH AMERICA: APHERESIS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 119
TABLE 70 NORTH AMERICA: APHERESIS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 119
TABLE 71 U.S.: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 120
TABLE 72 U.S.: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 121
TABLE 73 U.S.: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 121
TABLE 74 U.S.: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 121
TABLE 75 U.S.: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 122
TABLE 76 CANADA: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 122
TABLE 77 CANADA: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 123
TABLE 78 CANADA: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 123
TABLE 79 CANADA: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 123
TABLE 80 CANADA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 124
TABLE 81 EUROPE: APHERESIS MARKET SIZE, BY COUNTRY/REGION,
2014–2021 (USD MILLION) 126
TABLE 82 EUROPE: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 126
TABLE 83 EUROPE: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 126
TABLE 84 EUROPE: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 127
TABLE 85 EUROPE: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 127
TABLE 86 EUROPE: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 127
TABLE 87 GERMANY: APHERESIS MARKET SIZE, BY PROCEDURE,
2014–2021 (USD MILLION) 128
TABLE 88 GERMANY: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 128
TABLE 89 GERMANY: APHERESIS MARKET SIZE, BY DEVICE TYPE,
2014–2021 (USD MILLION) 129
TABLE 90 GERMANY: APHERESIS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 129
TABLE 91 GERMANY: APHERESIS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 129
TABLE 92 FRANCE: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 130
TABLE 93 FRANCE: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 131
TABLE 94 FRANCE: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 131
TABLE 95 FRANCE: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 131
TABLE 96 FRANCE: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 132
TABLE 97 U.K.: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 132
TABLE 98 U.K.: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 133
TABLE 99 U.K.: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 133
TABLE 100 U.K.: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 133
TABLE 101 U.K.: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 134
TABLE 102 ITALY: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 135
TABLE 103 ITALY: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 135
TABLE 104 ITALY: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 135
TABLE 105 ITALY: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 136
TABLE 106 ITALY: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 136
TABLE 107 SPAIN: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 137
TABLE 108 SPAIN: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 137
TABLE 109 SPAIN: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 137
TABLE 110 SPAIN: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 138
TABLE 111 SPAIN: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 138
TABLE 112 ROE: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 139
TABLE 113 ROE: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 139
TABLE 114 ROE: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 139
TABLE 115 ROE: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 140
TABLE 116 ROE: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 140
TABLE 117 APAC: APHERESIS MARKET SIZE, BY COUNTRY/REGION,
2014–2021 (USD MILLION) 142
TABLE 118 APAC: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 142
TABLE 119 APAC: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 142
TABLE 120 APAC: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 143
TABLE 121 APAC: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 143
TABLE 122 APAC: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 143
TABLE 123 JAPAN: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 144
TABLE 124 JAPAN: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 144
TABLE 125 JAPAN: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 145
TABLE 126 JAPAN: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 145
TABLE 127 JAPAN: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 145
TABLE 128 CHINA: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 146
TABLE 129 CHINA: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 147
TABLE 130 CHINA: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 147
TABLE 131 CHINA: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 147
TABLE 132 CHINA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 148
TABLE 133 INDIA: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 148
TABLE 134 INDIA: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 149
TABLE 135 INDIA: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION) 149
TABLE 136 INDIA: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 149
TABLE 137 INDIA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 150
TABLE 138 ROAPAC: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 151
TABLE 139 ROAPAC: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 151
TABLE 140 ROAPAC: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 151
TABLE 141 ROAPAC: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 152
TABLE 142 ROAPAC: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 152
TABLE 143 LATIN AMERICA: APHERESIS MARKET SIZE, BY COUNTRY/REGION,
2014–2021 (USD MILLION) 153
TABLE 144 LATIN AMERICA: APHERESIS MARKET SIZE, BY PROCEDURE,
2014–2021 (USD MILLION) 153
TABLE 145 LATIN AMERICA: APHERESIS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 153
TABLE 146 LATIN AMERICA: APHERESIS MARKET SIZE, BY DEVICE TYPE,
2014–2021 (USD MILLION) 154
TABLE 147 LATIN AMERICA: APHERESIS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 154
TABLE 148 LATIN AMERICA: APHERESIS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 154
TABLE 149 NUMBER OF HEMOPHILIA PATIENTS IN BRAZIL: 2012–2015 155
TABLE 150 BRAZIL: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 155
TABLE 151 BRAZIL: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 156
TABLE 152 BRAZIL: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 156
TABLE 153 BRAZIL: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 156
TABLE 154 BRAZIL: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 157
TABLE 155 MEXICO: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 157
TABLE 156 MEXICO: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 158
TABLE 157 MEXICO: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 158
TABLE 158 MEXICO: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 158
TABLE 159 MEXICO: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 159
TABLE 160 ROLA: APHERESIS MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION) 159
TABLE 161 ROLA: APHERESIS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 160
TABLE 162 ROLA: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014–2021 (USD MILLION) 160
TABLE 163 ROLA: APHERESIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 160
TABLE 164 ROLA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 161
TABLE 165 MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY PROCEDURE,
2014–2021 (USD MILLION) 161
TABLE 166 MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 162
TABLE 167 MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY DEVICE TYPE,
2014–2021 (USD MILLION) 162
TABLE 168 MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 162
TABLE 169 MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 163
TABLE 170 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2016 166
TABLE 171 MERGERS AND ACQUISITIONS, 2012–2015 167
TABLE 172 EXPANSIONS, 2013–2015 168
TABLE 173 PRODUCT LAUNCHES, 2015 168
TABLE 174 OTHER STRATEGIES, 2012–2015 169


LIST OF FIGURES

FIGURE 1 APHERESIS MARKET SEGMENTATION 19
FIGURE 2 RESEARCH DESIGN 22
FIGURE 3 BOTTOM-UP APPROACH 26
FIGURE 4 TOP-DOWN APPROACH 26
FIGURE 5 DATA TRIANGULATION METHODOLOGY 27
FIGURE 6 GLOBAL APHERESIS MARKET SIZE, BY PROCEDURE,
2016 VS. 2021 (USD MILLION) 30
FIGURE 7 GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY DISEASE,
2016 VS. 2021 (USD MILLION) 30
FIGURE 8 GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY PROCEDURE,
2016 VS. 2021 (USD MILLION) 31
FIGURE 9 GLOBAL APHERESIS MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION) 31
FIGURE 10 GLOBAL APHERESIS MARKET SIZE, BY DEVICE TYPE,
2016 VS. 2021 (USD MILLION) 32
FIGURE 11 GLOBAL APHERESIS MARKET SIZE, BY APPLICATION,
2016 VS. 2021 (USD MILLION) 32
FIGURE 12 GLOBAL APHERESIS MARKET SIZE, BY TECHNOLOGY,
2016 VS. 2021 (USD MILLION) 33
FIGURE 13 GLOBAL APHERESIS MARKET SIZE, BY CENTRIFUGATION TECHNOLOGY,
2016 VS. 2021 (USD MILLION) 33
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL APHERESIS MARKET 34
FIGURE 15 RISING PREVALENCE OF DISEASES AND GROWING NUMBER OF TRAUMA AND INJURY CASES DRIVING THE GROWTH OF THE APHERESIS MARKET 36
FIGURE 16 PLASMAPHERESIS COMMANDED THE LARGEST SHARE IN 2015 37
FIGURE 17 U.S. ACCOUNTED FOR LARGEST SHARE OF THE APHERESIS MARKET IN 2015 38
FIGURE 18 APAC TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD 39
FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD 39
FIGURE 20 APHERESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 41
FIGURE 21 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN THE U.S.
(MILLION INDIVIDUALS) 43
FIGURE 22 TYPE OF PLASMA PROCESSED WORLDWIDE, 1996–2012 (THOUSAND LITERS) 44
FIGURE 23 SOURCE PLASMA COLLECTION IN THE U.S. & EUROPE, 2005–2013
(THOUSAND LITERS) 44
FIGURE 24 PORTER’S FIVE FORCES ANALYSIS: APHERESIS MARKET 53
FIGURE 25 THERAPEUTIC APHERESIS, THE FASTEST-GROWING PROCEDURE SEGMENT OF THE APHERESIS MARKET 62
FIGURE 26 DISPOSABLES PRODUCT SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD 86
FIGURE 27 CENTRIFUGATION SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 98
FIGURE 28 OTHER APPLICATIONS TO WITNESS HIGHEST GROWTH IN THE APHERESIS MARKET 106
FIGURE 29 GEOGRAPHIC SNAPSHOT: MARKETS IN ASIA-PACIFIC ARE GROWTH HOTSPOTS 114
FIGURE 30 GLOBAL APHERESIS MARKET SHARE, BY REGION, 2015 VS. 2021 115
FIGURE 31 NORTH AMERICA: APHERESIS MARKET SNAPSHOT 117
FIGURE 32 EUROPE: APHERESIS MARKET SNAPSHOT 125
FIGURE 33 APAC: APHERESIS MARKET SNAPSHOT 141
FIGURE 34 AGREEMENTS, COLLABORATIONS, & PARTNERSHIPS, THE MOST-PREFERRED STRATEGIES BETWEEN 2012 AND 2016 164
FIGURE 35 GLOBAL APHERESIS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 165
FIGURE 36 BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, & PARTNERSHIPS, THE KEY STRATEGIES 166
FIGURE 37 GEOGRAPHIC REVENUE MIX OF MAJOR PLAYERS 170
FIGURE 38 CERUS CORPORATION: COMPANY SNAPSHOT (2015) 171
FIGURE 39 FRESENIUS MEDICAL CARE: COMPANY SNAPSHOT (2015) 175
FIGURE 40 FRESENIUS KABI: COMPANY SNAPSHOT (2015) 176
FIGURE 41 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2015) 178
FIGURE 42 HAEMONETICS CORPORATION: COMPANY SNAPSHOT (2015) 180
FIGURE 43 TERUMO CORPORATION: COMPANY SNAPSHOT (2015) 183
FIGURE 44 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2015) 188
FIGURE 45 KANEKA CORPORATION: COMPANY SNAPSHOT (2015) 190
FIGURE 46 KAWASUMI LABORATORIES, INC.: COMPANY SNAPSHOT (2015) 192
FIGURE 47 NIKKISO CO., LTD.: COMPANY SNAPSHOT (2015) 194


【レポートのキーワード】

アフェレーシス、血漿分離器、血漿成分分離器、血液灌流、消耗品、血漿交換、血液浄化療法、医療、処置、治療、アフェレーシス技術

★調査レポート[アフェレーシスの世界市場予測(~2021年):血漿分離器、血漿成分分離器、血液灌流、消耗品] ( Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) - Global Forecast to 2021 / MAM-MD-1407) 販売に関する免責事項
[アフェレーシスの世界市場予測(~2021年):血漿分離器、血漿成分分離器、血液灌流、消耗品] ( Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) - Global Forecast to 2021 / MAM-MD-1407) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆